These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Buruli ulcer: a mycobacterial skin ulcer in a Uganda child. DODGE OG; LUNN HF J Trop Med Hyg; 1962 Jun; 65():139-42. PubMed ID: 13886855 [No Abstract] [Full Text] [Related]
7. MYCOBACTERIAL SKIN ULCERS IN UGANDA: HISTOPATHOLOGICAL AND EXPERIMENTAL ASPECTS. DODGE OG J Pathol Bacteriol; 1964 Jul; 88():169-74. PubMed ID: 14194975 [No Abstract] [Full Text] [Related]
8. In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum. Banerjee DK; Holmes IB Chemotherapy; 1976; 22(3-4):242-52. PubMed ID: 1269290 [TBL] [Abstract][Full Text] [Related]
9. BURULI (MYCOBACTERIAL) ULCERATION IN UGANDA. (A NEW FOCUS OF BURULI ULCER IN MADI DISTRICT, UGANDA): REPORT OF A FIELD STUDY. LUNN HF; CONNOR DH; WILKS NE; BARNLEY GR; KAMUNVI F; CLANCEY JK; BEE JD East Afr Med J; 1965 Jun; 42():275-88. PubMed ID: 14341980 [No Abstract] [Full Text] [Related]
10. [Experience with the tuberculostatic effect of the phenazine derivative B-663 in vivo and in vitro]. URBANCIK R; TRNKA L; PAUKERT J Schweiz Z Tuberc Pneumonol; 1961; 18():432-9. PubMed ID: 13923895 [No Abstract] [Full Text] [Related]
11. Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo. Koval A; Bassanini I; Xu J; Tonelli M; Boido V; Sparatore F; Amant F; Annibali D; Leucci E; Sparatore A; Katanaev VL Eur J Med Chem; 2021 Oct; 222():113562. PubMed ID: 34116325 [TBL] [Abstract][Full Text] [Related]
12. Seasonal distribution of mycobacterial skin ulcers. Revill WD; Barker DJ Br J Prev Soc Med; 1972 Feb; 26(1):23-7. PubMed ID: 5016132 [No Abstract] [Full Text] [Related]
13. Study of a mycobacterium causing skin ulceration in Uganda. CLANCEY J; DODGE R; LUNN HF Ann Soc Belg Med Trop (1920); 1962 Aug; 42():585-90. PubMed ID: 14021473 [No Abstract] [Full Text] [Related]
15. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Revill WD; Morrow RH; Pike MC; Ateng J Lancet; 1973 Oct; 2(7834):873-7. PubMed ID: 4126917 [No Abstract] [Full Text] [Related]
16. Minimal effective dosages in mice of clofazimine (B,663) and of ethionamide against Mycobacterium leprae. Shepard CC Proc Soc Exp Biol Med; 1969 Oct; 132(1):120-4. PubMed ID: 4899207 [No Abstract] [Full Text] [Related]
17. Clofazimine ointment in the treatment of trophic ulcers. Ellis BP; Taube E S Afr Med J; 1973 Mar; 47(9):378-9. PubMed ID: 4690398 [No Abstract] [Full Text] [Related]
18. [Buruli skin ulcers]. van der Does CD Ned Tijdschr Geneeskd; 1968 Jul; 112(28):1292-4. PubMed ID: 5686179 [No Abstract] [Full Text] [Related]
19. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882 [TBL] [Abstract][Full Text] [Related]
20. Radiological abnormalities of the ileum associated with the use of clofazimine (Lamprene; B663) in the treatment of skin ulceration due to Mycobacterium ulcerans. de Bergeyck E; Janssens PG; de Muynck A Lepr Rev; 1980 Sep; 51(3):221-8. PubMed ID: 7442414 [No Abstract] [Full Text] [Related] [Next] [New Search]